Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$133.76
al cierre: Aug 20 EDT
$133.76
0.000.00%
Pre-comercialización: 4:00 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Silicon Laboratories Inc ha un obiettivo di prezzo di consenso pari a $152.79, stabilito in base alle ultime valutazioni degli analisti di 17. Le ultime 3 valutazioni degli analisti sono state rilasciate da Morgan Stanley, Barclays y Susquehanna il agosto 6, 2025, agosto 5, 2025 y julio 22, 2025. Con un obiettivo di prezzo medio di $141.33 tra le Morgan Stanley, Barclays y Susquehanna, c'è un implicito 5.66% upside per Silicon Laboratories Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Morgan Stanley
Barclays
Susquehanna
Stifel
Keybanc
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Silicon Laboratories
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/06/2025 | 7.66% | Morgan Stanley | $157 → $144 | Maintains | Equal-Weight | |||
08/05/2025 | -2.81% | Barclays | $100 → $130 | Maintains | Equal-Weight | |||
07/22/2025 | 12.14% | Susquehanna | $110 → $150 | Maintains | Neutral | |||
07/18/2025 | 19.62% | Stifel | $144 → $160 | Maintains | Buy | |||
07/08/2025 | 34.57% | Keybanc | $160 → $180 | Maintains | Overweight | |||
05/27/2025 | 19.62% | Benchmark | $160 → $160 | Reiterates | Buy → Buy | |||
05/14/2025 | -17.76% | Susquehanna | $100 → $110 | Maintains | Neutral | |||
05/14/2025 | 19.62% | Benchmark | $160 → $160 | Reiterates | Buy → Buy | |||
05/14/2025 | 12.14% | Needham | $150 → $150 | Reiterates | Buy → Buy | |||
04/22/2025 | -40.19% | Barclays | $120 → $80 | Maintains | Equal-Weight | |||
04/17/2025 | -10.29% | Stifel | $145 → $120 | Maintains | Buy | |||
03/12/2025 | 12.14% | Needham | $150 → $150 | Reiterates | Buy → Buy | |||
03/12/2025 | 19.62% | Benchmark | $160 → $160 | Reiterates | Buy → Buy | |||
02/05/2025 | 12.14% | Needham | $140 → $150 | Maintains | Buy | |||
02/05/2025 | 19.62% | Benchmark | $160 → $160 | Upgrade | Hold → Buy | |||
01/22/2025 | 19.62% | Keybanc | $115 → $160 | Maintains | Overweight | |||
01/17/2025 | -10.29% | Barclays | $75 → $120 | Maintains | Equal-Weight | |||
01/06/2025 | 8.4% | Stifel | $135 → $145 | Maintains | Buy | |||
12/17/2024 | 4.67% | Needham | $120 → $140 | Maintains | Buy | |||
12/17/2024 | -2.81% | Susquehanna | → $130 | Initiates | → Neutral | |||
11/05/2024 | -14.03% | Keybanc | $150 → $115 | Maintains | Overweight | |||
11/05/2024 | -27.48% | Morgan Stanley | $123 → $97 | Maintains | Equal-Weight | |||
11/05/2024 | — | Benchmark | — | Reiterates | → Hold | |||
11/05/2024 | 0.93% | JP Morgan | $150 → $135 | Maintains | Overweight | |||
11/05/2024 | 0.93% | Stifel | $160 → $135 | Maintains | Buy | |||
11/05/2024 | -43.93% | Barclays | $120 → $75 | Maintains | Equal-Weight | |||
07/25/2024 | 12.14% | Needham | $150 → $150 | Reiterates | Buy → Buy | |||
04/25/2024 | -10.29% | Citigroup | $137 → $120 | Maintains | Neutral | |||
04/25/2024 | -10.29% | Barclays | $140 → $120 | Maintains | Equal-Weight | |||
04/25/2024 | 12.14% | JP Morgan | $165 → $150 | Maintains | Overweight | |||
04/25/2024 | — | Benchmark | — | Reiterates | → Hold | |||
04/25/2024 | 12.14% | Needham | → $150 | Upgrade | Hold → Buy | |||
02/08/2024 | 4.67% | Barclays | $120 → $140 | Maintains | Equal-Weight | |||
02/08/2024 | 23.36% | JP Morgan | $145 → $165 | Maintains | Overweight | |||
01/16/2024 | -10.29% | Barclays | $80 → $120 | Maintains | Equal-Weight | |||
01/02/2024 | 15.88% | Stifel | $136 → $155 | Maintains | Buy | |||
12/08/2023 | 8.4% | JP Morgan | → $145 | Initiates | → Overweight | |||
11/02/2023 | -35.71% | Morgan Stanley | $110 → $86 | Maintains | Equal-Weight | |||
11/02/2023 | -2.81% | Keybanc | $180 → $130 | Maintains | Overweight | |||
11/02/2023 | — | Barclays | — | Upgrade | Underweight → Equal-Weight | |||
10/30/2023 | -17.76% | Morgan Stanley | $154 → $110 | Maintains | Equal-Weight | |||
10/19/2023 | 27.09% | Stifel | $186 → $170 | Maintains | Buy | |||
07/31/2023 | 10.65% | Citigroup | $165 → $148 | Maintains | Neutral | |||
07/27/2023 | 15.13% | Morgan Stanley | $159 → $154 | Maintains | Equal-Weight | |||
07/27/2023 | 34.57% | Keybanc | $200 → $180 | Maintains | Overweight | |||
07/07/2023 | — | Raymond James | — | Initiates | → Market Perform | |||
05/31/2023 | 23.36% | Citigroup | $186 → $165 | Maintains | Neutral | |||
04/27/2023 | 18.87% | Morgan Stanley | $207 → $159 | Maintains | Equal-Weight | |||
04/27/2023 | 34.57% | TD Cowen | $200 → $180 | Maintains | Outperform | |||
04/27/2023 | 49.52% | Keybanc | $210 → $200 | Maintains | Overweight | |||
02/07/2023 | 39.06% | Citigroup | $150 → $186 | Maintains | Neutral | |||
02/02/2023 | 42.05% | Wells Fargo | $155 → $190 | Maintains | Overweight | |||
02/02/2023 | 49.52% | Cowen & Co. | $175 → $200 | Maintains | Outperform | |||
02/02/2023 | 54.75% | Morgan Stanley | $151 → $207 | Maintains | Equal-Weight | |||
02/02/2023 | — | Summit Insights Group | — | Upgrade | Hold → Buy | |||
02/02/2023 | 57% | Keybanc | $160 → $210 | Maintains | Overweight | |||
01/23/2023 | -25.24% | Barclays | $85 → $100 | Maintains | Underweight | |||
01/09/2023 | 15.88% | Wells Fargo | $145 → $155 | Maintains | Overweight | |||
10/27/2022 | -36.45% | Barclays | $95 → $85 | Maintains | Underweight | |||
10/27/2022 | 12.89% | Morgan Stanley | $161 → $151 | Maintains | Equal-Weight | |||
10/27/2022 | — | Needham | — | Downgrade | Buy → Hold | |||
10/27/2022 | 19.62% | Keybanc | $180 → $160 | Maintains | Overweight | |||
10/24/2022 | -28.98% | Barclays | $140 → $95 | Downgrade | Equal-Weight → Underweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Silicon Laboratories (SLAB)?
El último precio objetivo de Silicon Laboratories (NASDAQ:SLAB) fue comunicado por Morgan Stanley el agosto 6, 2025. La firma de analistas fijó un precio objetivo para $144.00 que espera SLAB a rise dentro de 12 meses (un posible 7.66% upside). 26 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Silicon Laboratories (SLAB)?
La última calificación de analistas para Silicon Laboratories (NASDAQ:SLAB) fue proporcionada por Morgan Stanley, y Silicon Laboratories mantuvo su equal-weight calificación.
¿Cuándo se produjo la última revisión al alza de Silicon Laboratories (SLAB)?
La última revisión al alza de Silicon Laboratories Inc se produjo en febrero 5, 2025, cuando Benchmark elevó su precio objetivo a $160. Benchmark anteriormente tenía a hold para Silicon Laboratories Inc.
¿Cuándo fue la última revisión a la baja de Silicon Laboratories (SLAB)?
La última revisión a la baja de Silicon Laboratories Inc se produjo en octubre 27, 2022, cuando Needham cambió su precio objetivo de N/A a N/A para Silicon Laboratories Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Silicon Laboratories (SLAB)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Silicon Laboratories, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Silicon Laboratories se registró el agosto 6, 2025, por lo que la próxima calificación estará disponible en torno al agosto 6, 2026.
¿Es correcta la calificación de los analistas sobre Silicon Laboratories (SLAB)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Silicon Laboratories (SLAB) fue un mantuvo con un precio objetivo de $157.00 a $144.00. El precio actual al que cotiza Silicon Laboratories (SLAB) es de $133.76, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.